UNHW: A 44% Weekly Income ETF Outside of Tech—Worth the Risk?

Most of my income portfolio revolves around technology. Funds like CHPY, FEP, QQQI, and others have done well, but they all share one common risk: when semiconductors struggle, much of my income portfolio feels the impact.

That naturally led me to ask:

Where can I generate income that isn't tied to tech?

The search brought me to UNHW, Roundhill's Weekly Pay ETF based on UnitedHealth Group (UNH).

Unlike diversified ETFs, this is a single-stock ETF, meaning everything depends on one company.

Understanding UnitedHealth Group

Before evaluating the ETF, it's important to understand the business behind it.

UnitedHealth is America's largest health insurer, generating over $440 billion in annual revenue while serving roughly 150 million people.

Its business operates through two primary divisions:

• UnitedHealthcare, which provides employer health plans, Medicare Advantage, and Medicaid coverage.

• Optum, which focuses on pharmacy benefits, healthcare services, analytics, and technology.

As an investment, however, UnitedHealth has experienced significant volatility.

During 2025, the stock lost more than half its value due to:

• Rising medical costs

• A Department of Justice investigation into Medicare Advantage billing

• Leadership changes

The stock eventually bottomed near $234 before staging an impressive recovery during 2026 after stronger-than-expected earnings and improved guidance.

While much of the rebound has already occurred, two major uncertainties remain:

• The DOJ investigation is still unresolved.

• Berkshire Hathaway exited its entire position earlier this year.

The easy recovery may already be behind investors. The next phase depends on whether UnitedHealth can continue executing.

This is where the fund becomes very different from most income ETFs.

Unlike the covered call funds that make up much of my portfolio, UNHW doesn't sell options.

Instead, according to its prospectus, the fund holds:

• Swap agreements tied to UnitedHealth

• Shares of UnitedHealth

• Short-term Treasury securities used as collateral

Its objective is to deliver approximately 120% of UnitedHealth's weekly return, measured from Friday's close to the following Friday's close.

That means:

• If UNH gains 5% in a week, the fund targets roughly a 6% gain.

• If UNH falls 5%, the fund targets roughly a 6% loss.

The leverage works both ways and resets every week.

This is probably the most misunderstood part of the fund.

There are no covered call premiums generating income.

Instead, Roundhill calculates weekly distributions based on:

• UnitedHealth's recent performance

• The stock's implied volatility

The distributions change from week to week.

One week may pay around $0.29 per share, while another may distribute $0.46.

The prospectus also states that most distributions are expected to be classified as Return of Capital (ROC).

That's an important distinction.

Unlike option-income funds, where ROC often reflects tax treatment of option gains, UNHW's ROC is built directly into the design of the fund.

If UnitedHealth continues rising, those gains help support distributions.

If the stock declines, distributions continue—but they're effectively being paid from a shrinking asset base.

This isn't traditional income generation. It's a payout policy wrapped around a leveraged investment.

If you look up UNHW on portfolio tracking platforms, you'll notice something confusing.

The trailing yield appears much lower than the advertised 44%.

That's because the ETF only launched in December 2025 and doesn't yet have a full twelve months of distributions.

The forward distribution rate reflects the fund's current payout formula, while the trailing yield is based on incomplete history.

It's important to understand which number you're looking at before making any assumptions.

Looking at Performance

The fund's short history tells an interesting story.

UNHW launched around $53 per share.

When UnitedHealth ran into serious problems, the ETF fell below $34, representing roughly a 38% drawdown in only eight weeks.

Later, stronger earnings helped fuel a sharp recovery, sending the ETF back above its launch price while continuing to make weekly distributions.

That recovery demonstrates both the potential upside—and the significant downside—of this strategy.

When I first started researching UNHW, I thought it might serve as a hedge against my technology-heavy portfolio.

After digging deeper, I realized that wasn't the right way to think about it.

A hedge should help protect a portfolio when other holdings decline.

UNHW doesn't do that.

It's still a leveraged investment in a single stock.

Instead, I now see it as a diversifier.

Its returns depend on healthcare—not semiconductors, AI, or the NASDAQ.

That's valuable because it provides exposure to a completely different sector, but it's important not to confuse diversification with downside protection.

Every position should have a purpose.

If UNHW ever earns a place in my portfolio, its job would be to generate weekly income from healthcare—not to protect my portfolio during market declines.

After reading the prospectus carefully, three issues stood out.

1. The Risk Stack

This ETF combines several layers of risk:

• Single-stock concentration

• 1.2x leverage

• Ongoing regulatory uncertainty surrounding UnitedHealth

If the DOJ investigation produces unfavorable outcomes, the ETF would likely amplify the downside.

2. Roundhill's Own Warning

The prospectus contains unusually direct language.

Roundhill specifically states that this fund is not suitable for all investors and should only be owned by investors who understand the strategy and actively monitor their positions.

That's worth paying attention to.

This isn't a buy-and-forget income fund.

3. A Surprising Prospectus Error

One detail actually made me stop.

Inside a section discussing UnitedHealth, the prospectus mistakenly references Oracle Corporation.

Clearly, it's a copy-and-paste error from another filing.

Does that change how the ETF functions?

No.

But it serves as a reminder that these single-stock products are launching quickly—and reinforces why investors should always read the documents themselves instead of relying solely on marketing materials.

Trust, but verify.

For now, I'm waiting.

Healthcare remains one of the biggest gaps in my income portfolio, and UNHW is certainly interesting because it provides weekly income outside of technology.

However, several factors keep me on the sidelines:

• The unresolved DOJ investigation

• The fund's leverage

• Its dependence on a single company

• The need for active monitoring

I also have another important date on my calendar.

UnitedHealth's upcoming earnings report will provide another major test for both the stock and the ETF.

I'd rather watch how the fund performs through another earnings cycle before committing any capital.

Sometimes the best investment decision is simply being patient.

UNHW is one of the more unique income ETFs I've researched.

It offers exposure to healthcare, weekly distributions, and a completely different strategy from traditional covered call funds.

At the same time, it comes with meaningful risks that shouldn't be ignored.

For now, I'll continue watching from the sidelines while researching other healthcare income opportunities—including State Street's XLVI sector income ETF.

Healthcare remains an area I want to add to my portfolio. I'm just not convinced that UNHW is the right vehicle yet.

As always, I'll continue sharing what I learn as I build my income portfolio in public.